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ABSTRACT The size of a synaptic vesicle (SV) is generally thought to be determined by the amount of lipid and membrane
protein it contains. Once formed, it is thought to remain constant in size. Using ﬂuorescence correlation spectroscopy and cryo-
genic electron microscopy, we show that glutamatergic vesicles reversibly increase their size upon ﬁlling with glutamate. The
increase (~25% in diameter) corresponds to an increase in surface area of ~50% and in volume of ~100%. This large size
increase implies a large structural change in the SV upon loading with neurotransmitters. Vesicles lacking SV protein 2A
(SV2A) did not manifest a change in size after loading with glutamate, indicating that SV2A is required for this phenomenon.INTRODUCTION
Synaptic vesicles (SVs) are small organelles (~40 nm in diam-
eter) that mediate quantal chemical communication between
neurons (1,2). SVs can be viewed as distinct compartments
defined by a lipid bilayer, and their size is generally thought
to be determined by the amount of membrane they contain.
Neurotransmitters are loaded into SVs by transporter proteins
in their membrane that utilize an electrochemical gradient to
drive transmitter uptake. This gradient is established by
a vacuolar-type ATPase that uses energy derived from ATP
hydrolysis to translocate protons into the vesicle interior,
thus creating both a pH gradient and a potential gradient
that fuels the uptake and storage of the transmitter (2).
Previous studies using slices (3) and cultured PC12 cells (4)
reported that vesicles with greater numbers of vesicular trans-
porters (3) or neurotransmitters (4) have a larger average size
in electron microscopy (EM) images. This size increase was
assumed to be caused by incorporation of additional
membrane proteins (e.g., transporters (3)) or lipids into the
vesicle, because a membrane-dominated organelle would
not be able to increase its size significantly without incorpo-
rating additional materials into the lipid bilayer. For example,
synthetic lipid vesicles burst when their diameter is increased
by a mere ~0.7% to ~2.5% (corresponding to a critical areal
strain of 1.3–5.1%), depending on the composition of the
membrane (5).
Here, we show that isolated SVs in solution reversibly
increase in size after filling with the neurotransmitter gluta-
mate, with no apparent addition of lipid or protein molecules.
This suggests that SVs undergo large structural changes as
the vesicle fills with neurotransmitter, and that the presence
of the neurotransmitter may be encoded in the vesicle size.
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SV isolation
SVs were isolated from commercially purchased stripped rat brains (Pel-
Freeze, Rogers, AR) or from green fluorescent protein (GFP)-transfected
(synaptopHluorin) mouse brains. Briefly, the stripped rat brains were ground
with liquid nitrogen in a Waring blender and then homogenized in 50 mM
HEPES, 2 mM EGTA, 0.3 M sucrose, pH 7.4, with 10 strokes in a glass-
Teflon homogenizer. The homogenate was spun at 100,000  g for
28 min to pellet cell debris. The supernatant containing SVs was removed
for further purification and the pellet was discarded. The supernatant
was then layered onto a 1.5/0.6 M sucrose step gradient and spun at
260,000  g for 72 min, after which SVs were removed from the interface
between the sucrose layers. Vesicles were flash-frozen in separate 0.5 mL
aliquots and stored at –80C until needed.
SV labeling
Before labeling, the vesicles were dialyzed in a 10,000MWCOSlide-a-Lyzer
cassette (Pierce, Rockford, Illinois) against assay buffer (10 mM HEPES,
4 mM KCl, 4 mM MgSO4, 0.3 M sucrose, pH 7.4) overnight at 4
C. After
dialysis, the SVs were incubated with an excess of primary antibody against
SV2A (polyclonal) or against synaptotagmin (monoclonal) at 20C for
15 min. Next, the vesicles were incubated with a fluorescent secondary anti-
body (either Alexa Fluor 633 goat anti-rabbit IgG or Alexa Fluor 488 goat
anti-rabbit IgG; Invitrogen, Carlsbad, CA) at 20C for 15 min. Removal of
excess antibody was accomplished by incubation with IgG-conjugated
agarose beads specific for the primary antibody (rabbit IgG agarose; Sigma-
Aldrich, St. Louis, MO) and the secondary antibody (anti-goat IgG agarose;
Sigma-Aldrich) in two separate steps. Vesicles were incubated for 45 min at
20Cwith each type of IgG-conjugated agarose bead, and the beadswere then
removed by centrifugation at 1000 g for 2 min. The vesicles were stored on
ice in assay buffer until just before the loading was performed. The same
procedure was followed for GFP-transfected vesicles.
Fluorescence correlation spectroscopy
measurements
For fluorescence correlation spectroscopy (FCS) measurements, fluores-
cently tagged SVs in solution (~30–50 mL) were placed on a glass coverslip
above the objective. To ensure consistency in the measurements, we focused
the laser probe volume at 25 mm above the surface of the coverslip into the
sample droplet. The samples were excited with light from a 632.8 nm HeNe
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diode pumped laser (Sapphire; Coherent). Fluorescence was collected via
an avalanche photodiode (APD SPCM-AQR-16; PerkinElmer, Fremont,
CA). To initiate glutamate uptake, we added ATP and glutamate at the
desired concentration to the SVs and allowed them to incubate at room
temperature for 10 min. At the start of each experiment, calibration measure-
ments were performed using 60 nm polystyrene beads. To produce the auto-
correlation curve, sample fluorescence was collected for 2 min, with five
autocorrelation curves collected for each sample droplet. Multiple data
sets (3–6) were collected for each sample per day. The collected autocorre-
lation data were fitted to obtain the average diffusion coefficient of the parti-
cles. The standard deviations (SDs) of the percent change in average SV
diameter were on the order of 5%.
FCS simulations
Details of the FCS simulation can be found in one of our previous publica-
tions (6). For this work, we investigated the effect of a heterogeneous sample
on the FCS signal and the apparent diffusion coefficient obtained from that
signal. Briefly, the simulation sample consisted of 40 spheres confined to a
spherical volume, which was 8 mm in diameter. Each simulation represented
an FCS measurement of 60 s. The nonglutamate vesicles were represented
by spheres with a diameter of 60 nm. The loaded glutamate vesicles were
represented by spheres with a range of diameters (66.5, 74.1, 83.0, 93.7,
and 107.0 nm). For each loaded glutamate vesicles of given diameter, we
ran a series of simulations with different percentages of loaded glutamate
vesicles; the results were the average best-fit hydrodynamic diameters
from 18 FCS simulations. Other details of the simulation, as well as the
fitting procedure used to extract the diffusion coefficients from which the
hydrodynamic diameters were obtained, were the same as those reported
in Kuyper et al. (6).
Cryogenic electron microscopy
Cryogenic electron microscopy (cryo-EM) was performed on purified vesi-
cles that were dialyzed into 230 mM glycine, 10 mM HEPES, 4 mM KCl,
and 4 mM MgSO4. For loaded vesicles, 1 mM glutamate and 1 mM ATP
were added and allowed to equilibrate for 10 min at room temperature before
freezing. Unloaded vesicles were used without further modification after the
dialysis. The vesicles were applied to a holey carbon-coated grid, rapidly
frozen in liquid ethane, and maintained at ~100 K with a Gatan (Pleasanton,
CA) 626 cryoholder. Images were recorded on a Gatan 1024  1024 CCD
camera mounted in a FEI Tecnai F30 electron microscope (FEI, Hillsboro,
OR), which was operated at 300 kV at a nominal magnification of
49,000 and underfocused 10–20 mm. Two separate experiments were per-
formed with the data from the two experiments collated into one set for
presentation purposes. From these images, vesicle diameters were measured
from the outer edge of the black ring, where two diameters orthogonal to one
another were measured and averaged. There were a small number of
membrane organelles with diameters > 100 nm in the images, which we
excluded from the data set.
RESULTS
Measurements of SVs by FCS
We purified SVs from rat or mouse brains. For FCS experi-
ments, the SVs were labeled with antibodies directed against
SV-specific proteins (SV2A or synaptotagmin), which were
in turn labeled with fluorescent secondary antibodies. FCS,
a technique that measures the size of objects by measuring
their diffusion, was performed on an in-house-built instru-
ment (Fig. 1 A) (6,7). Fig. 1, B and C, show the raw timeBiophysical Journal 97(9) 2577–2584trace and the resultant autocorrelation curve, respectively,
as SVs in solution transit the FCS probe volume. The FCS
setup was calibrated with a range of size standards
(20–200 nm fluorescent beads; Fig. 1 D), and our FCS
measurements were checked for accuracy with 60 nm beads
before each run. To label vesicles, we used an antibody
against the membrane protein SV2A. SV2A is present on
all glutamatergic vesicles in the central nervous system.
Although its molecular action is not known, analyses of
SV2A knockout mice indicate that it is not involved in
neurotransmitter loading (8,9). The diffusion coefficient or
hydrodynamic diameter for SV2A antibody-labeled SVs
was measured with both single- and dual-color FCS. Up to
five correlation curves were collected for each sample (un-
loaded, loaded, etc.) at one time, and each experiment was
performed multiple times to confirm the results. The percent
change was calculated for each day’s collected data along
with the relative SD of the percent change. The percent
change from multiple days was collated to form a single
data set from which the error bars are derived. It is important
to note that each collection of correlation curves is a separate
experiment; we are not attempting to distinguish between
FIGURE 1 FCS setup and method. (A) Schematic of the in-house built
instrument used to perform FCS. DC: dichroic mirror; APD: avalanche
photodiode; BP: bandpass filter. (B) Typical raw time trace of the fluores-
cence signals obtained from antibody-labeled SVs and (C) the correspond-
ing autocorrelation function. (D) Calibration plot for our FCS instrument
using fluorescent beads of known diameters (24 5 4 nm, 36 5 5 nm,
60 5 3 nm, and 210 5 10 nm, 5 SD). The hydrodynamic diameters of
four different-sized polystyrene beads were measured to ensure that the
FCS setup was calibrated for a wide range of sizes. The linear correlation
coefficient is 0.99.
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solution with FCS.
To determine whether the presence of antibodies affected
the diffusion coefficient of the SVs, we measured SVs in
the presence or absence of antibodies. These studies were
performed using vesicles isolated from mice expressing
synaptopHluorin (10). SynaptopHluorin vesicles have a
pH-sensitive GFP fused to the lumenal domain of the vesicle
protein VAMP/synaptobrevin. This provides a fluorescent
vesicle whose diffusion coefficient can be measured by FCS
in the absence of antibodies. We did not perform loading
experiments with synaptopHluorin vesicles because the pH-
sensitive GFP is not fluorescent at pH < 6.0. As SVs load
glutamate, the interior of the vesicle acidifies to a pH of
~5.5, and thus the synaptopHluorin vesicles become invisible
when they load glutamate. We measured the diffusion coeffi-
cient of synaptopHluorin vesicles and antibody-labeled (anti-
synatpotagmin primary antibody and Alexa633 secondary
antibody) synaptopHluorin vesicles. The diffusion coeffi-
cients were identical within the error of the assay, which
shows that the measured diffusion coefficient is not affected
by the presence of a few antibodies on the vesicle exterior
(see Fig. S1 and Table S1 in the Supporting Material).
Isolated SVs double their volume upon loading
with glutamate
SVs purified from brain do not contain glutamate, due to
transmitter leakage during purification in the absence of
ATP (11). Incubating SVs in a loading buffer (LB) contain-
ing ATP and glutamate induces refilling (12,13) of vesicles.
We compared the hydrodynamic diameter of ‘‘empty’’ or
‘‘unloaded’’ SVs with that of vesicles filled with glutamate.
We found that the filling of SVs caused the measured hydro-
dynamic diameter to increase by 23.9%5 4.8% (SD of the
percent change; Fig. 2 A). Removal of either glutamate or
ATP prevented this observed size increase (Fig. 2 A).
The dramatic increase in SV size did not occur when the
uptake of glutamate was blocked by competitive (Trypan
blue) (14) or noncompetitive (rose Bengal) (15) inhibitors
of the vesicular glutamate transporter, VGLUT1 (Fig. 2 A).
The size increase was also blocked when the electrochemical
gradient required for uptake was abolished, as in the absence
of ATP or in the presence of bafilomycin, an inhibitor of the
Hþ/ATPase (16) (Fig. 2, A and B). These results show that
the size increase is a direct consequence of glutamate loading.
We found that the increase in vesicle size depended on the
extravesicular glutamate concentration up to 0.25 mM
(Fig. 2 B), consistent with the observation that VGLUT1
activity is modulated by external glutamate concentrations
(17). Additionally, the observed size increase also depended
on the extravesicular concentration of ATP (Fig. 2 C). Below
~0.8 mM ATP, we did not observe any appreciable size
increase, which is consistent with the previously measured
apparent Km (0.8–2 mM) for exogenous ATP determinedunder standard assay conditions for glutamate loading (18).
Therefore, the observed increase in vesicle size again
appears to be a direct result of the loading of neurotransmit-
ters into the vesicle.
For our FCS measurements, we failed to observe any size
increase when VGLUT1 was labeled directly with antibodies
(data not shown), likely because direct attachment of anti-
bodies to VGLUT1 interfered with the proper functioning
of the transporter. Therefore, we used antibodies against
a protein present on all SVs (SV2A or synaptotagmin)
(19). As a result, the actual size increase for glutamatergic
vesicles is likely higher because a fraction of the vesicles
in our preparation are not glutamatergic. To understand
how the presence of unloaded vesicles might affect average
FCS values, we carried out a series of simulations in which
we calculated the size increase of loaded glutamatergic
vesicles as a percentage of the measured FCS diameter
for unloaded vesicles and the percentage of glutamatergic
vesicles present (Fig. 2 D). We estimate that glutamatergic
vesicles constitute ~80% of all SVs, based on the observation
that GABAergic vesicles make up ~16% of the total vesicle
population (20), and an estimate that cholinergic and aminer-
gic vesicles are present at ~4%. Therefore, if we estimate that
~20% of the vesicles are unloaded and do not change size,
the actual hydrodynamic diameter increase is 31.7%
(Fig. 2 D, inset).
To rule out vesicle aggregation or fusion as a cause of the
observed size increase, we measured average fluorescence
intensity of unloaded and loaded vesicles as they transited
the FCS probe volume (Fig. 3A).We found the average inten-
sity to be identical for unloaded and loaded vesicles (Fig. 3A),
indicating that the observed size increase was not caused by
the aggregation or fusion of two or more vesicles. Aggrega-
tion or fusion of vesicles should produce an increase in the
average intensity because more fluorescent antibodies would
be bound to the larger vesicle. To further dismiss fusion as
a cause, we measured vesicle size in the presence of
the calcium chelator EGTA, which inhibits Ca2þ-induced
vesicle fusion. Fig. 3B shows that SVs treatedwith EGTA ex-
hibited the same size increase as untreated SVs; therefore,
Ca2þ-induced fusion is not responsible for the size increase.
We also checked to see whether a difference in osmotic
pressure would cause the vesicles to change size. For this
experiment, SVs in buffer (10 mM HEPES, 4 mM KCl,
4 mM MgSO4, 320 mM sucrose, pH 7.4) were diluted
with distilled water by 50% and then allowed to sit for
10 min at room temperature. We found that the measured
hydrodynamic size of these vesicles was no different from
that of unloaded vesicles in buffer. The pressure difference
created by changing the osmotic strength of the buffer by
half does not by itself appear to be sufficient to cause the vesi-
cles to change size appreciably.
Most importantly, we were able to reverse the size increase
by treating loaded SVs with exogenous ATPase (Fig. 3 B),
which led to a rundown of the electrochemical gradient andBiophysical Journal 97(9) 2577–2584
2580 Budzinski et al.FIGURE 2 SVs show an increase in size upon loading with glutamate. All
plots show percent change 5 SD of percent change. (A) Plot showing the
change in hydrodynamic diameter of rat SVs under various loading condi-
tions. The LB consisted of 10 mM HEPES, 4 mM KCl, 4 mM MgSO4,
320 mM sucrose, 1 mM ATP, and 1 mM glutamate at pH 7.4; ATP and
glutamate were added separately and the vesicles were allowed to load for
10 min at room temperature. The glycine LB (buffer used in cryo-EM) con-
sisted of 10 mM HEPES, 4 mM KCl, 4 mM MgSO4, 230 mM glycine,
1 mM ATP, and 1 mM glutamate at pH 7.4. ‘‘LB no ATP’’: LB without
ATP; ‘‘LB no glut’’: LB without glutamate; ‘‘LB þ rose Bengal’’: LB
with 1 mM rose Bengal; ‘‘LB þ trypan blue’’: LB with 1.25 mM Trypan
blue; ‘‘LB þ baf’’: LB with 0.6 mM bafilomycin. Inset shows the visibleBiophysical Journal 97(9) 2577–2584leakage of glutamate. SVs were loaded with glutamate and
ATP at room temperature, and then treated with 0.6 U
ATPase for 2 min. The correlation curves revealed that the
SVs had returned to the unloaded size, indicating that the
size increase is reversible. Whatever changes the vesicles
undergo during loading, the process is reversible once the
loading conditions are removed. It is difficult to imagine
a fusion event that could be reversed due to the presence of
ATPase. These data also suggest an internal control for the
FCS measurements, as any unforeseen environmental differ-
ences between unloaded and loaded vesicle solutions would
not be reversed by the addition of ATPase. Therefore, the
measured size increase appears to be due to the vesicle filling
with transmitter and is not an artifact of the experimental
design.
Cryo-EM
To determine whether the increase in hydrodynamic diam-
eter represents an actual expansion of the vesicle, we con-
ducted cryo-EM studies on unstained, plunge-frozen vesicles
imaged directly in vitrified ice (Fig. 4). Cryo-EM images
were taken of unloaded SVs (n ¼ 200) and SVs incubated
under loading conditions (n ¼ 186), and analyzed. Fig. 4 A
shows a histogram distribution of the diameters of unloaded
and loaded vesicles, demonstrating a shift to larger size upon
filling. To quantify the size increase, we graphed the data as
a cumulative probability plot (Fig. 4 B). From this plot, we
calculate that the average vesicle diameter (mean 5 SD)
increased from 45.7 5 13.9 nm to 56.9 5 17.1 nm, corre-
sponding to a 24.5% 5 1.2% increase in diameter and
91.8% 5 4.6% increase in volume (Fig. 4 A, inset). To
correct for the presence of nonglutamatergic vesicles, we
difference in the autocorrelation function between ‘‘unloaded’’ vesicles
and ‘‘loaded’’ vesicles. (B) Graph showing percent increase in hydrody-
namic diameter of loaded SVs as a function of the extravesicular glutamate
concentration; ATP concentration was 1 mM for all, and bafilomycin
concentration was 0.6 mM for the lower curve. (C) Graph showing the
percent increase in hydrodynamic diameter of loaded vesicles as a function
of extravesicular ATP concentration; glutamate concentration was 1 mM for
all. (D) Simulation showing the apparent increase in hydrodynamic diameter
versus percentage of glutamate vesicles in our FCS samples. The simulated
unloaded and nonglutamatergic vesicles in the sample have a hydrodynamic
diameter of 60 nm, whereas the loaded glutamate vesicles were simulated
with hydrodynamic diameters of (B) 66.5, (-) 74.1, (D) 83.0, () 93.7, and
(>) 107.0 nm. Each point for 60–100% glutamatergic vesicles is the
average of best-fit results for 18 simulations. The results for the 20% and
40% points are the average from six simulations. The result for the 0% point
is the average from 12 simulations. The diameters have all been converted to
percent increases (shown on the right of the plot) for comparison with our
experimental measurements. Typical values of the SD of the best fit results
are shown for some of the points, and solid lines have been drawn to guide
the eye. The horizontal dashed line was drawn at 23.9% increase, the
measured percent increase in the hydrodynamic diameter of the loaded
SVs measured by FCS. The vertical dashed line is drawn at 80%, which
is the estimate of the percentage of glutamatergic vesicles. The intersection
of the two dashed lines is used to estimate the percentage increase of the
hydrodynamic diameter of the glutamatergic vesicles only.
Synaptic Vesicles Increase in Size 2581subtracted 20% of the unloaded vesicle (shaded bars) popu-
lation in each size bin from the number of loaded vesicles
(hatched bars). This yielded an average diameter for the
loaded vesicles of 59.1 5 5.6 nm, which corresponds to
an increase in diameter of 29.3% (Fig. 4 C). The increase
in vesicle size, therefore, appears to be the result of an expan-
sion of the vesicle.
Vesicles lacking SV2A do not show a size increase
with loading
We found that the size increase required the presence of SV2A
(Fig. 5). SVs isolated from either SV2A knockout (AKO) or
SV2A/SV2B double knockout (DKO) mice (labeled with
anti-synaptotagmin) did not exhibit a size increase upon
loading with glutamate, whereas SVs from wild-type (WT)
mice did. In WT vesicles (labeled with anti-synaptotagmin),
FIGURE 3 SVs are not aggregated or fused under our measurement
conditions. (A) A plot of the average fluorescence intensity (arbitrary
units) 5 SD of SVs as they transit the laser probe volume under the three
conditions indicated on the x axis. All measurements were performed in
LB consisting of 10 mM HEPES, 4 mM KCl, 4 mM MgSO4, 320 mM
sucrose, 1 mMATP, and 1 mM glutamate at pH 7.4, except for ‘‘Unloaded’’
vesicles, which were in LB without glutamate and ATP, and ‘‘Loaded
w/ EGTA’’ vesicles, whichwere in LBplus 1mMEGTA. (B)Vesicles loaded
under the following conditions: 1, LB plus 1 mM EGTA (‘‘EGTA’’); 2,
loaded in LB and then treated with 0.6U ATPase (‘‘ATPase’’) for 2 min;
and 3, unloaded vesicles diluted 50% by the addition of distilled water
(‘‘50%Water’’). The plot gives the percent change5 SD of percent change.
For all experiments, loading was performed at room temperature for 10 min.the size increase upon loading was similar to that measured
with SVs from rat (20.8% 5 1.8%; Fig. 5 A). SVs from
mice heterozygous (Het) for the SV2A gene were also tested.
Het SV2A vesicles, which have roughly half the amount of
SV2A as homozygous vesicles (Fig. 5 B), showed a reduced
size increase of 15.2%5 3.9% upon loading with glutamate.
Thus, the change in vesicle size involves more proteins than
just the proteins involved in neurotransmitter loading (i.e.,
VGLUT or V0-ATPase).
DISCUSSION
In contrast to previous in vivo observations (3,4), our in vitro
measurements of isolated SVs in solution indicate that SVs can
undergo large size changeswithout sources of additional lipids
or proteins, and that this ability to change size requires the
presence of SV2A. Change in the vesicle structure could be
induced by the establishment of an electrochemical gradient
leading to the presence of luminal glutamate, which could
influence the conformation of vesicle membrane proteins.
The size change of glutamatergic vesicles we report here is
strikingly similar to irreversible and reversible size changes
observed in viruses. During maturation or cell entry, viral
capsids can undergo irreversible expansion (for phages, typi-
cally a ~20% increase in diameter, leading to a near doubling
of volume) or contraction (HIV and other lentiviruses, papil-
lomaviruses, and an insect virus, Nudaurelia capensis
u-virus) (21). These significant dimensional changes, which
are critical for viral function, are brought about by substantial
alterations of the associated capsid proteins. Reversible size
changes also occur in virus capsids. In the case of theNudaur-
elia capensis u-virus capsid, a normally irreversible
shrinkage is rendered reversible via changes in pH in the
absence of a required proteolytic cleavage (22). Cowpea chlo-
rotic mottle virus (CCMV) reversibly expands and contracts
with changes in pH and Mg2þ or Ca2þ concentration (23).
Poliovirus (24) and Flock House virus (25) undergo a revers-
ible ‘‘breathing’’ transition that exposes internal protein enti-
ties to antibodies and proteases. This transition likely
produces a larger particle as an intermediate in the transition,
a final product, or both. In similarity to reversible viral transi-
tions, SVs are apparently able to undergo large structural
changes as a function of glutamate loading.
Fig. 6 provides an island model for the SV, which shows
a size increase similar to that experienced by CCMV, and an
internal-matrix swelling model. In Fig. 6 A, SVs are modeled
as having white ‘‘islands’’ of nonexpandable components
composed mostly of lipid molecules. The ‘‘islands’’ are sur-
rounded by a gray ‘‘sea’’ comprised of expandable compo-
nents, most likely protein clusters (26). As the SV loads
glutamate, the proteins undergo a conformational change,
leading to an expansion of the ‘‘sea’’. This model mimics
the reversible expansion of the CCMV (Fig. 6 B), which
increases 20% in diameter. CCMV expands via the intercap-
somere connections, with the capsomere cores remaining theBiophysical Journal 97(9) 2577–2584
2582 Budzinski et al.FIGURE 4 Cryo-EMmeasurements of vesicle diameter reveal an increase
in size upon glutamate loading. (A) Histogram showing the distribution of
diameters for unloaded and loaded SVs in glycine LB (10 mM HEPES,
4 mM KCl, 4 mM MgSO4, 230 mM glycine, 1 mM ATP, and 1 mM gluta-
mate at pH 7.4). Inset shows percent increase in diameter for loaded vesicles.
(B) Cumulative probability plot of diameters for unloaded and loaded vesi-
cles. Plots were fit with a lognormal distribution to obtain a diameter of
45.75 13.9 nm (mean5 SD) for unloaded and 56.95 17.1 nm for loadedBiophysical Journal 97(9) 2577–2584same size. The intercapsomere connections are comprised of
protein domains, analogously to the SV protein clusters that
have been reported upon detergent solubilization (26).
Since vesicles without SV2A did not increase in size, but
still accumulate glutamate in vivo (8), SV2A likely contrib-
utes to the structural change that vesicles undergo as a conse-
quence of glutamate loading. SV2A is predicted to contain
12 transmembrane domains, making it one of the larger
SV proteins. A recent tomography study of SV2A suggests
vesicles. Inset shows representative pictures for unloaded and loaded vesi-
cles. (C) Histogram showing the distribution in diameters for glutamatergic
vesicles only, which was calculated by subtracting from each size bin 20%
of the number of empty vesicles (shaded bars) from the number of loaded
vesicles (hatched bars); inset shows this corrected percent increase in diam-
eter for loaded glutamatergic vesicles.
FIGURE 5 Dependence of vesicle size increase on the presence of SV2A.
(A) A bar plot showing the increase in vesicle size requires SV2A. SVs iso-
lated from WT mice, heterozygous SV2A mice (AHet), SV2A knockout
mice (AKO), or SV2A/SV2B double knockout mice (DKO) were loaded
at room temperature for 10 min in LB (10 mM HEPES, 4 mM KCl,
4 mM MgSO4, 320 mM sucrose, 1 mM ATP, and 1 mM glutamate at
pH 7.4). These vesicles were all labeled with antibodies against synaptotag-
min. (B) Western blot comparing SV2A and synaptophysin content in WT
mice, AHet mice, and AKO mice. The bar graph shows the ratio of SV2A
expression versus the expression of synaptophysin, a common SV marker
protein, normalized to the expression level in WT mice. Proteins were
probed with a polyclonal antibody directed against SV2A and a polyclonal
antibody directed against synaptophysin. As anticipated, AHet vesicles
(n ¼ 4) have about half the amount of expressed SV2A as WT vesicles
(n ¼ 4), whereas vesicles from AKO (n ¼ 3) mice contain no SV2A. All
vesicles exhibited similar levels of synaptophysin.
that it exists in two conformations: a cytoplasmic-facing
conformation and an intravesicular-facing conformation
(27). These conformational differences suggest a high degree
of flexibility in the SV2A structure. Additionally, SV2A is
a distant relative of prestin, a novel motor protein that has
been proposed to produce changes in hair cell length in the
auditory system (28,29). Like SV2A, prestin shares struc-
FIGURE 6 Models of SV expansion. (A) Island model. In this model
(left), nonexpandable components (most likely lipids) are modeled as white
islands corresponding to ~65% of the surface area. The remaining surface
area (gray) represents expandable components, most likely proteins.
Loading glutamate causes the protein ‘‘sea’’ to expand, whereas the
‘‘islands’’ do not change size appreciably. Holes may form in the islands
or the sea, but can be plugged by expansion of the internal matrix. The
expanded model (right) represents a ~25% increase in diameter. The size,
shape, and arrangement of islands in these depictions are arbitrary. (B)
Our model is analogous to the reversible expansion of CCMV. Three-dimen-
sional reconstructions of the unexpanded (left) and expanded (right) states
are shown (23). Unexpanded CCMV is ~29 nm in diameter and is formed
by pentameric (white arrowhead) and hexameric (black arrowhead) oligo-
mers known as capsomeres. The expanded form is ~20% larger in diameter.
SVs could expand in a similar manner. Analogously to the ‘‘islands’’ in our
model, the cores of CCMV hexamers and pentamers remain the same size,
whereas the intercapsomere connections expand. In CCMV, the expandable
intercapsomere connections are protein domains. (C) Matrix-swelling
model. In this model, the vesicle size increase is caused by expansion of
the internal matrix upon glutamate loading. The internal matrix expands
and pushes the membrane outward, possibly causing the formation of holes
in the membrane (shown as brackets in the membrane). Loaded glutamate is
held in the internal matrix, thus keeping the vesicle from leaking glutamate
after the expansion occurs.
Synaptic Vesicles Increase in Sizetural features with solute transporters, though it does not
appear to act as a transporter. In response to changes in
membrane potential, prestin undergoes a large conforma-
tional change that can change cell shape by as much as 5%
(29). We note, however, that these predicted changes in
SV2 conformation are not of sufficient magnitude to
completely account for the size changes reported here.
In cholinergic vesicles, SV2A is a keratin sulfate proteo-
glycan (30), and its large sugar moieties appear to constitute
a significant proportion of the glycolytic matrix in SVs (31).
Similar matrices have been shown to expand in size,
doubling their volume, with changes in ionic strength (31).
This suggests that the vesicular matrix may undergo a struc-
tural transition due to the formation of the electrochemical
gradient or the presence of neurotransmitter inside the
vesicle. The existence of an insoluble polymer-like matrix
would ensure that vesicular contents are retained if holes
form in the vesicle membrane as a result of the size increase
(32). Fig. 6 C depicts this scenario as an internal-matrix
swelling model. In this model, neurotransmitter is concen-
tratedwithin an internal matrix that needs to undergo swelling
before transmitter can be released (33). SV2A modulates the
number of vesicles competent for fusion (8,34,35).
Combining the fact that the loss of SV2A reduces release
probability with the finding that in the absence of SV2A the
vesicles do not increase in size upon glutamate loading,
a model emerges in which swelling of the SV2-linked internal
matrix may signal that vesicles are ready for release.
Alternatively, it is possible that, rather than playing a direct
role in the size change, SV2A plays an indirect role by influ-
encing the protein composition of vesicles. Loss of SV2 has
been linked to changes in the levels of other SV proteins
(36); thus, vesicles lacking SV2A, which is the major iso-
form of SV2 in vertebrate CNS, may lack a protein compo-
nent required for the size change seen in WT vesicles. SV2A
may contribute to changes in vesicle size in multiple ways.
Future research will determine whether the size change
reported here is a direct or indirect action of SV2A, and
how this size change contributes to vesicle functioning.
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